«UKRAINIAN PSYCHEDELIC RESEARCH ASSOCIATION» - UPRA | Ukrainian Psychedelic Research Association | психоделічно асистована терапія | ПАТ

Population of Ukraine in 2023–2024 is approximately 33.5 million (1)

15.4 million Ukrainians

over 3 years of full-scale war and 11 years of Russian invasion are experiencing mental health issues, according to WHO data. (2)

8.4 million Ukrainians

are at risk of developing mental disorders due to military actions, forced displacement, and the loss of loved ones. (3)

5.1 million Ukrainians

may have a diagnosis of post-traumatic stress disorder (PTSD), as the prevalence of PTSD among people living in war conditions can reach 15.3%. (4)

PTSD is a mental condition that occurs after experiencing or witnessing a life-threatening event. Key symptoms include severe emotional instability, aggression attacks, nightmares, and intrusive memories of the traumatic event.

Only

55%

of these patients are expected to recover completely after conventional therapy courses.

How can we help
the remaining 45%?

The answer is psychedelic-assisted therapy

Psychedelic-Assisted Therapy is a method of combining the effects of psychotherapy and psychedelic compounds. Such a method is proven to have a significant therapeutic superiority compared to existing treatments of PTSD and depression.

Breakthrough therapy designation

2017

MDMA

US Food and Drug Administration (FDA) has granted the breakthrough therapy designation for MDMA for the treatment of PTSD.

2019

Psilocybin

US Food and Drug Administration (FDA) has granted the breakthrough therapy designation for psilocybin for the treatment of Major Depressive Disorder.

2024

LSD

The U.S. Food and Drug Administration (FDA) recognized the use of Lysergide d-tartrate (MM120) as a breakthrough therapy for GAD (generalized anxiety disorder).

He lost a friend in the war. He lost his fingers, foot, spleen and sense of life. The PTSD diagnosis, antidepressants — panic attacks have not disappeared. His reason for living was lost. But psychedelic therapy worked.

"My life has changed in one session."

Stanislav Gibadulin,
call sign Hitman.

Served in the Armed Forces from the beginning of the war in Donbas.

Read Hitman's story

UPRA is a non-profit organization advancing the clinical use of psychedelics in PTSD patients who have exhausted conventional therapeutic options. Together with partners, we work to change the legal framework, promote expanded access programs, educate health practitioners and support patients and their caregivers.